恆騰網絡(00136.HK)向騰訊(00700.HK)等溢價逾9%配股 淨籌3億元
恆騰網絡(00136.HK)公布,向騰訊(00700.HK)間接全資擁有附屬Water Lily及獨立資深投資者劉學恆分別配售6,400萬股及5,600萬股,共佔公司擴大後股本約1.28%,每股作價2.5元,較昨日(25日)收市價2.29元溢價約9.17%。淨集共約3億元,擬用作集團之一般營運資金及業務發展及擴張。
完成後,騰訊附屬Water Lily於恆騰網絡持股量將由19.7%增至20.13%;劉學恆則持股0.6%。
公司認為,Water Lily股份認購協議簽訂後將有利於公司進一步完善公司的資本結構,同時為未來業務發展及產業投資提供資金支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.